Literature DB >> 19197884

Surgical treatment of late congenital dislocation of the hip (after 4 years of age).

F Cigala1, F M Lotito, F Sadile.   

Abstract

The goal of the surgical treatment in previously untreated juvenile hip displacement is to achieve a stable and concentric reduction of the femoral head with the best range of motion and without severe complications related to avascular necrosis (AVN) and stiffness of hip joint. In this paper the authors describe their approach in the treatment of the patients affected by neglected high dislocation of the hip joint observed after 4 years of age, when all of them had been ambulant for several years. They point out, on the basis of their experience, the importance of avoiding damage to the vessel supply of the dislocated femoral head, respecting the soft tissue and the use of different surgical techniques to perform acetabuloplasty in relation to skeletal age, in order to obtain good hip stability and congruency, good range of motion for 20 years at least, and to prepare the hip joint for further surgical intervention in the best way possible when inevitable osteoarthritis occurs.

Entities:  

Year:  2007        PMID: 19197884

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  2 in total

1.  Postoperative redislocation of the hip in a patient with congenital insensitivity to pain with anhidrosis: A case report and review of literature.

Authors:  Rui Wang; Yi Liu; Yi-Yi Zhou; Jia-Ying Wang; Zhu-Jie Xu; Sha-Yang Chen; Qi-Qi Wang; Peng Yuan
Journal:  World J Clin Cases       Date:  2018-11-26       Impact factor: 1.337

2.  The effect of traditional Chinese medicine fumigation and washing as a complementary and alternative therapy on the recovery of joint function after development dysplasia of the hip in children: A protocol for systematic review and meta-analysis.

Authors:  Weipeng Zeng; Hanru Mao; Gang Zhou; Kaiqiu Wu; Xinping Liao; Linqian Yun; Jianping Lin
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.